#Truvada

PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.

Studies of the link between tenofovir use and coronavirus infection or COVID-19 outcomes have yielded mixed results.

Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.

A low-cost generic version of Truvada as PrEP will hit the market September 30.

Safeway and other Albertsons pharmacies will also participate, allowing uninsured clients to fill PrEP prescriptions at no cost.

The 2-1-1 HIV prevention regimen offers an option for those who don’t want to take daily pills.

Scripts and testing don’t require visits to the doc thanks to this partnership between Texas Health Action and the telemedicine portals.

A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

Both Truvada and Descovy are highly effective and safe for most people taking PrEP, but the newer option has more cost barriers.

Treatment as prevention is a great thing. But everything about these meds, including the drug info in the black boxes, is important.

More than 50 AIDS and LGBT groups demand the tech giant remove “dangerous and misleading” PrEP ads.

The U.S. Health Department launched “Ready, Set, PrEP” to provide the HIV prevention med at no cost.

The pop star’s party is named after the HIV prevention drug and is meant as an homage to ’80s-era queer nightlife.